The Pharmaceutical Journal
Vol 274 No 7346 p483
23 April 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Hep C early treatment

Patients infected with hepatitis C who have normal liver enzyme levels may benefit from early therapy with peginterferon alfa and ribavirin, suggest data presented at the 40th annual meeting of the European Association for the Study of the Liver in Paris last week.